Biosecurity
How can we prevent future pandemics and accelerate progress in the life sciences?
COVID-19 has revealed both strengths and weaknesses in our biosecurity response. On the one hand, the pandemic exposed how weak and ineffectual our public health systems are at controlling highly contagious airborne respiratory diseases. On the other hand, the urgency of the moment — combined with decades of previous investment — enabled us to deliver mRNA vaccines in less than nine months. The life sciences contain much more low-hanging fruit that is ripe to be picked — if only we can implement the right public policies.
Biosecurity
Latest Publication
How To Reuse the Operation Warp Speed Model
To replicate the success of OWS, we need to identify the specific characteristics that made it effective
Read the full report
Biosecurity
Three Reasons Congress Should Fund Biodefense
Cutting the Chemical Biological Defense Program would be penny-wise and pound-foolish
Read the full report
Biosecurity
Research Into Far-UVC Systems Can Help Us Prevent the Next Pandemic
A response to the EPA's request for information on better indoor air quality management
Read the full report
Biosecurity
Dwindling Food Reserves Are a National Security Risk
Policymakers have allowed the critical national security tool of food reserves to rust
Read the full report
Biosecurity
Food Reserves, Global Food Security, and International Stability
Incentivizing farmers to hold food reserves would protect global food security
Read the full report
Biosecurity
Why the Department of Defense Should Invest in Biosurveillance
Building integrated, layered, and pathogen-agnostic detection systems
Read the full report
Biosecurity
Weighing the Cost of the Pandemic
Knowing what we know now, how much damage did COVID-19 cause in the United States?
Read the full report
Biosecurity
Creating Advance Market Commitments and Prizes for Pandemic Preparedness
Read the full report
